Advertisement
Organisation › Details
Allecra Therapeutics (Group)
Allecra is a biopharmaceutical company established in 2013 in the European BioValley Life Sciences cluster located in the Upper Rhine valley around the Basel region of northwest Switzerland including southwest Germany and the Alsace Region of France. Allecra is focused on the development of novel treatments to combat multi drugresistant Gram-negative bacterial infections. Allecra’s mission is to contribute towards the global effort to combat antibiotic resistance by developing new treatments which overcome emerging resistance mechanisms, thereby saving lives of patients whose infections may otherwise be inadequately treated. Allecra is supported by existing investors Forbion, Delos Capital, EdRIP, Xeraya Capital, EMBL Ventures, BioMed Partners and Nicholas Benedict. Allecra’s wholly-owned French subsidiary is a beneficiary of financial support from the French public bank Bpifrance and from the Région Alsace. *
Start | 2013-04-01 established | |
Today | Allecra Therapeutics GmbH | |
Industry | AAI101 (Allecra Therapeutics) | |
Industry 2 | AAI202 (Allecra Therapeutics) | |
Person | Benedict, Nicholas (Vaderis Therapeutics 202208 CEO + Co-Foudner formerly Allecra Therapeutics) | |
Person 2 | Reithinger, Holger (Forbion 201004– Managing Director Forbion Capital Partners Munich before GLSV Munich + 3i Germany) | |
Region | Weil am Rhein | |
Country | Germany | |
Street | 9 Im Kränzliacker | |
City | 79576 Weil am Rhein | |
Tel | +41-79-592-2005 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Allecra Therapeutics GmbH. (3/26/18). "Press Release: Allecra Therapeutics Announces Positive Top-Line Results from Phase 2 CACTUS Study of Its Lead Candidate, AAI101, in Combination with Cefepime to Treat Complicated Urinary Tract Infections (cUTI)". Lö | ||
Record changed: 2023-12-30 |
Advertisement
More documents for Allecra Therapeutics (Group)
- [1] Santhera Pharmaceuticals Holding AG. (1/24/20). "Press Release: Santhera Appoints New Chief Financial Officer". Pratteln....
- [2] Allecra Therapeutics GmbH. (4/3/18). "Press Release: Allecra Therapeutics Announces Participation at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo, Monaco on April 8-10,2018". Lörrach & Saint Louis....
- [3] Allecra Therapeutics GmbH. (3/26/18). "Press Release: Allecra Therapeutics Announces Positive Top-Line Results from Phase 2 CACTUS Study of Its Lead Candidate, AAI101, in Combination with Cefepime to Treat Complicated Urinary Tract Infections (cUTI)". Lö...
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top